[Skip to Content]
[Skip to Content Landing]
February 23, 2000

Psychotropic Drug Use in Very Young Children

Author Affiliations

Author Affiliation: Departments of Psychiatry and Neuroscience, Harvard Medical School, Boston, Mass.

JAMA. 2000;283(8):1059-1060. doi:10.1001/jama.283.8.1059

The study by Zito and colleagues1 in this issue of THE JOURNAL on the use of psychotropic medications in very young children in 2 Medicaid programs and a managed care organization suggests that 1% to 1.5% of all children 2 to 4 years old enrolled in these programs currently are receiving stimulants, antidepressants, or antipsychotic medications. The authors also report that the prevalence of neuropsychopharmacologic interventions in this age group increased substantially during the last decade.

First Page Preview View Large
First page PDF preview
First page PDF preview